98%
921
2 minutes
20
Perioperative care in the United States is largely based on current fee-for-service models. Fee-for-service models are not based on the true cost of services provided, charges do not equal costs, and reimbursement varies based on insurer. Value-based health care is defined as patient-centered outcomes over cost of providing these services. Process mapping and time-driven activity-based costing can be used to define actual cost of services provided. Outcomes after discharge can be measured, so that the overall value of care provided can be assessed and improved based on the outcomes and costs identified.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.anclin.2023.08.005 | DOI Listing |
J Robot Surg
September 2025
Department of Orthopedic Surgery, Orthopedic and Rheumatology Institute, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, A4144195, USA.
Robotic-assisted total joint arthroplasty (RA-TJA) is projected to account for 70% of all arthroplasties by 2030, yet its economic value and operational efficiency have yet to be thoroughly synthesized. While early literature emphasized technical precision, evolving payment models and implementation costs have shifted focus toward cost-effectiveness and workflow integration. To evaluate the economic and institutional viability of RA-TJA by synthesizing available evidence on capital costs, perioperative expenses, learning curves, throughput, and long-term adoption trends.
View Article and Find Full Text PDFPopul Health Manag
September 2025
Jefferson College of Population Health, Philadelphia, Pennsylvania, USA.
Social determinants of health (SDOH) have a greater impact on health outcomes than clinical care. It is essential to address SDOH to improve population health outcomes and achieve success in value-based care models. Primary care delivery models have increased the focus on screening for SDOH to meet these needs.
View Article and Find Full Text PDFPalliat Med Rep
June 2025
Department of Nursing, Tamsui Mackay Memorial Hospital, New Taipei, Taiwan.
Background: Aneurysmal subarachnoid hemorrhage (aSAH) carries high mortality rates and often requires critical family decisions about code status when complications occur. The American Heart Association provides treatment guidelines but acknowledges a significant knowledge gap regarding do-not-resuscitate or do-not-intubate (DNR/DNI) decisions in patients with aSAH, challenging clinicians in identifying appropriate timing for these discussions.
Aim: To identify demographic and clinical physiological factors associated with code status transition in adults with aSAH admitted to the intensive care unit, supporting value-based decision making through more informed and timely discussions between health care providers and families that align with patients' core values and preferences.
Eur J Health Econ
September 2025
Erasmus School of Health Policy & Management, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR, Rotterdam, The Netherlands.
Background: Policymakers face challenges in developing pricing policies for potentially innovative healthcare technologies (pIHTs) that balance limited budgets, access, and incentives for innovation. This study aimed to map existing evidence and identify knowledge gaps regarding price determinants and pricing policies for pIHTs and their effect on access and sustainability.
Methods: We conducted a scoping Review of scientific and grey literature in English published between 2014 and September 2023 with pre-specified inclusion and exclusion criteria to identify stakeholder-informed price determinants, pricing policies applied by European Economic Area (EEA) or Organisation for Economic Cooperation and Development (OECD) member states, and their access-related impacts.
Health Policy
August 2025
University of Twente, EL-IPS - European Lab for Innovative Purchasing and Supply, Drienerlolaan 5, NL-7522 NB Enschede, the Netherlands.
Background: The procurement function in the health and care workforce is pivotal for enabling innovation, sustainability, and value-based resource allocation. Yet, its workforce development remains underexplored in public health and health policy research.
Objective: To develop a role-based model of innovation procurement capacity in health and care, identifying emerging roles and associated competencies needed within complex public health systems.